Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-045752
Filing Date
2018-08-07
Accepted
2018-08-07 18:07:56
Documents
2
Period of Report
2018-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1638
2 POA DOCUMENT poa.txt EX-24.3_804443 1607
  Complete submission text file 0001209191-18-045752.txt   4898
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540
Business Address
Tursi James Patrick (Reporting) CIK: 0001527710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32302 | Film No.: 18999376